Product Overview
Semax + Selank Blend
The Semax + Selank Blend combines two synthetic peptide compounds that have been the subject of ongoing investigation in peptide chemistry, molecular biology, and neuropeptide research. Selank is a synthetic heptapeptide with the amino acid sequence Thr-Lys-Pro-Arg-Pro-Gly-Pro and was originally developed as a modified analog of the endogenous peptide tuftsin. Semax is a synthetic peptide derived from fragments of adrenocorticotropic hormone (ACTH) and consists of a seven-amino-acid sequence designed for peptide research applications.
Together, these compounds provide a defined molecular framework for studying peptide structure, receptor-binding characteristics, molecular interactions, and related biochemical processes. Researchers utilize Semax and Selank in laboratory settings to investigate peptide stability, structure–activity relationships, analytical characterization, and experimental models involving synthetic neuropeptide analogs.
The combination is frequently employed in comparative peptide studies and controlled research protocols focused on understanding the physicochemical properties and molecular behavior of peptide compounds under laboratory conditions.
Research Use Only. Not for human or veterinary use.
Disclaimer: Not intended to diagnose, treat, cure, or prevent any disease.